Comparison
2q13 Microdeletion Syndrome C6012360 vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between 2q13 Microdeletion Syndrome and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
2q13 Microdeletion Syndrome C6012360
A rare genetic condition where a small piece of chromosome 2 is missing. It can affect development and cause distinctive features. Care involves multiple specialists based on symptoms.
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
2q13 Microdeletion Syndrome C6012360
Variable
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
2q13 Microdeletion Syndrome C6012360
severe
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
2q13 Microdeletion Syndrome C6012360
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
2q13 Microdeletion Syndrome C6012360
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
2q13 Microdeletion Syndrome C6012360
congenital
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
2q13 Microdeletion Syndrome C6012360
rare-disease
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
2q13-microdeletion-syndrome-C6012360 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q13 Microdeletion Syndrome C6012360 | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Chromosomal change | Loss of material at chromosome 2q13. | Gain of material at chromosome 15q11q13. | High |
| Development | Developmental effects may occur, but the pattern is not established here. | Delays, learning difficulty, and sometimes autism-spectrum traits are described. | Moderate |
| Reported severity | Source severity label is severe. | Source severity label is moderate. | Low |
When to favor each condition
Choose 2q13 Microdeletion Syndrome C6012360 when
Testing identifies a 2q13 deletion
The genetic finding directly matches the left condition.
High
Congenital developmental concerns without a 15q gain
A rare 2q13 deletion can be considered pending confirmation.
Moderate
Recognition occurs at a variable age
The supplied onset is variable rather than limited to ages 0–3.
Low
Choose 15q11q13 Microduplication Syndrome C2675336 when
Testing identifies a 15q11q13 duplication
The copy-number gain matches the right condition.
High
Early developmental delay with learning or autism-spectrum traits
This fits the supplied description but is not specific alone.
Moderate
Concerns begin from birth to age 3
The supplied onset range is 0–3 years.
Low
How key tests differ
| Test | 2q13 Microdeletion Syndrome C6012360 | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show copy-number loss at 2q13. | May show copy-number gain at 15q11q13. | The result can distinguish deletion from duplication; clinical relevance needs genetics review. |
| Methylation or parent-of-origin testing | No specific role is established by the supplied data. | The region overlaps Prader-Willi and Angelman regions, but duplication meaning is not established here. | Do not equate this duplication with either syndrome. |
| Developmental assessment | Documents individual needs; no cutoff is supplied. | Documents delay, learning, or behavior; no cutoff is supplied. | Supports care planning but does not establish the diagnosis. |
Prognosis comparison
2q13 Microdeletion Syndrome C6012360
- Outcome
- Long-term outcome is not established; the source labels severity as severe.
- Factors
- Deletion content, associated findings, and support may influence course, but effects are not quantified.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- Severity is labeled moderate, with variable developmental and learning needs.
- Factors
- Duplication extent, neurodevelopment, and therapy access may matter; predictors are not supplied.
Time frame: Both are chronic; left onset is variable and right onset is ages 0–3.
Confirmed genetics, associated findings, and supportive care require clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental disability | Possible, although the range is not established. Developmental delay and learning difficulty are described. Support should be individualized. |
| Behavioral features | Not specifically established in the source. Autism-spectrum traits are sometimes reported. Screening should be clinician-directed. |
| Other congenital findings | Distinctive features may occur, but details are not supplied. Features beyond neurodevelopment are not specified here. Do not assume organ complications without evaluation. |
Patient education highlights
- HighGenetic result
A chromosomal finding needs genetics interpretation of its size, genes, and possible inheritance.
- HighTransmission
Neither condition is contagious; both are congenital genetic changes.
- MediumSupportive care
Therapies are tailored to symptoms. No specific treatment dose is established here.